Clinical and scientific progress related to the interface between cardiology and psychology: Lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam

Netherlands Heart Journal

Volumn 19, Issue 11, 2011, Pages 470-476

  Erdman, R A M ^a   Pedersen, S S ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Behavioural factors; Cardiac psychology; Heart disease; Review

Indexed keywords

CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL DECISION MAKING; CLINICAL PSYCHOLOGY; DOCTOR PATIENT RELATION; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEART REHABILITATION; HUMAN; INTERDISCIPLINARY COMMUNICATION; MEDICAL RESEARCH; NETHERLANDS; PATIENT CARE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SCREENING TEST; WORK EXPERIENCE;

EID: 83155177211     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0190-5     Document Type: Review

References (50)

1. Guarneri E, Horrigan BJ, Pechura CM. The efficacy and cost effectiveness of integrative medicine: a review of the medical and corporate literature. Explore (NY). 2010;6:308-12.
2. Pedersen SS, van Domburg RT, Theuns DAMJ, et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149:664-9.
3. Wijbenga JAM, Duivenvoorden HJ, Balk AHMM, et al. Quality of life in chronic heart failure. Validation of the Dutch version of the Minnesota Living with Heart Failure Questionnaire. Cardiologie. 1998;5:627-31.
4. Erdman RAM. Medisch psychologische vragenlijst voor hartpatiënten (MPVH). Lisse: Swets & Zeitlinger; 1982.
5. Utens EM. Information provision for patients undergoing cardiac surgery: a randomized controlled clinical trial [Voorlichting aan hartchirurgische patienten: Een gerandomizeerd gecontroleerd interventie-onderzoek]. Rotterdam: Erasmus Medical Center; 1989.
6. Van der Vlugt MJ, Pedersen SS, Boersma E, et al. Early discharge of patients with acute myocardial infarction has no adverse psychological consequences. Coron Health Care. 2001;5:73-9.
7. Erdman RA, Duivenvoorden HJ, Verhage F, et al. Cardiac rehabilitation: a 5-year follow-up study of mental functioning, work resumption, smoking habits and sports activities. Ned Tijdschr Geneeskd. 1984;128:846-51.
8. Serlie AW, Erdman RA, Passchier J, et al. Psychological aspects of non-cardiac chest pain. Psychother Psychosom. 1995;64:62-73.
9. van Berkel TF, Boersma H, Roos-Hesselink JW, et al. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J. 1999;20:1773-82.
10. Utens EM, Verhulst FC, Erdman RA, et al. Psychosocial functioning of young adults after surgical correction for congenital heart disease in childhood: a follow-up study. J Psychosom Res. 1994;38:745-58.
11. Bleeker JK, Simoons ML, Erdman RA, et al. Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The Netherlands. Br J Gen Pract. 1995;45:181-4.
12. Appels A, Bar F, van der Pol G, et al. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT). Psychosom Med. 2005;67:217-23.
13. Pedersen SS, Holkamp PG, Caliskan K, et al. Type D personality is associated with impaired health-related quality of life 7 years following heart transplantation. J Psychosom Res. 2006;61:791-5.
14. Pedersen SS, Spek V, Theuns DA, et al. Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life. Trials. 2009;10:120.
15. Pedersen SS, den Broek KC, Theuns DAMJ, et al. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int J Cardiol. 2009;00.
16. Smolderen KG, Hoeks SE, Pedersen SS, et al. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med. 2009;14:297-304.
17. Pedersen SS, Van den Berg M, Erdman RAM, et al. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks and personality. Pacing Clin Electrophysiol. 2009;32:184-92.
18. Pedersen SS, van Domburg RT, Theuns DA, et al. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med. 2004;66:714-9.
19. Pedersen SS, Lemos PA, van Vooren PR, et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol. 2004;44:997-1001.
20. Pedersen SS, van den Broek KC, Erdman RAM, et al. Pre implantation ICD concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace. 2010;12:1446-52.
21. Utens EM, Verhulst FC, Meijboom FJ, et al. Behavioural and emotional problems in children and adolescents with congenital heart disease. Psychol Med. 1993;23:415-24.
22. van Rijen EH, Utens EM, Roos-Hesselink JW, et al. Longitudinal development of psychopathology in an adult congenital heart disease cohort. Int J Cardiol. 2005;99:315-23.
23. Pedersen SS, Denollet J, de Jonge P, et al. Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med. 2009;24:1037-42.
24. Pedersen SS, Kupper HM, Denollet J. Psychological factors and heart disease. In: Camm J, Lüscher T, Serruys PW, editors. ESC textbook of cardiovascular medicine. 2nd ed. Oxford: Oxford University Press; 2009.
25. Mommersteeg PM, Denollet J, Spertus JA, et al. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157:208-18.
26. Dickens C, McGowan L, Percival C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med. 2008;70:450-5.
27. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763-74.
28. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and CORONARY HEART DISEASE. Recommendations for Screening, Referral, and Treatment. A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008.
29. Whooley MA. To screen or not to screen? Depression in patients with cardiovascular disease. J Am Coll Cardiol. 2009;54:891-3.
30. Davidson KW, Korin MR. Depression and cardiovascular disease: selected findings, controversies, and clinical implications from 2009. Cleve Clin J Med. 2010;77 Suppl 3:S20-6.
31. Hoeks SE, Smolderen KG, et al. Clinical validity of a diseasespecific health status questionnaire: the peripheral artery questionnaire. J Vasc Surg. 2009;49:371-7.
32. Smolderen KG, Hoeks SE, Aquarius AE, et al. Further validation of the peripheral artery questionnaire: results from a peripheral vascular surgery survey in the Netherlands. Eur J Vasc Endovasc Surg. 2008;36:582-91.
33. van der Vlugt MJ, van Domburg RT, Pedersen SS, et al. Feelings of being disabled as a risk factor for mortality up to 8 years after acute myocardial infarction. J Psychosom Res. 2005;59:247-53.
34. Plevier CM, Mooy JM, Marang-Van de Mheen PJ, et al. Persistent impaired emotional functioning in survivors of a myocardial infarction? Qual Life Res. 2001;10:123-32.
35. Simsek C, Pedersen SS, van Gestel YR, et al. Feelings of being disabled as a prognostic factor for mortality in the drug-eluting stent era. J Psychosom Res. 2009;67:85-91.
36. Frizelle DJ, Lewin B, Kaye G, et al. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol. 2006;11:293-301.
37. Spertus JA. Evolving applications for patient-centered health status measures. Circulation. 2008;118:2103-10.
38. McGrady A, McGinnis R, Badenhop D, et al. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009;29:358-64.
39. Uniken Venema-van Uden MM, Zoeteweij MW, Erdman RA, et al. Medical, social and psychological recovery after cardiac rehabilitation. J Psychosom Res. 1989;33:651-6.
40. Pelle AJ, Erdman RA, van Domburg RT, et al. Type D patients report poorer health status prior to and after cardiac rehabilitation compared with non-type D patients. Ann Behav Med. 2008;36:167-75.
41. Corra U, Piepoli MF, Carre F, et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2010;31:1967-74.
42. Beckie TM, Beckstead JW, Schocken DD, et al. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int J Nurs Stud. In Press.
43. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16:121-37.
44. Frasure-Smith N, Lesperance F. Depression and cardiac risk: present status and future directions. Heart. 2010;96:173-6.
45. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359:677-87.
46. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10:S1-10.
47. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. Jama. 2003;289:3106-16.
48. Rollman BL, Belnap BH, LeMenager MS, et al. The Bypassing the Blues treatment protocol: stepped collaborative care for treating post-CABG depression. Psychosom Med. 2009;71:217-30.
49. Cooney MT, Storey S, Taylor L, et al. EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III-a comparison of Irish and European results. Ir Med J. 2009;102:113-6.
50. Hendriks KS, Hendriks MM, Birnie E, et al. Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm. 2008;5:719-24.